Cash-price audit · saxagliptin / Onglyza / generic marketed since 2023 / generic with coupon ~$48/mo Sponsor RxGrab →
RXGRAB/DRUG PRICING/SAXAGLIPTIN
Drugs · DPP-4 inhibitor

Saxagliptin Cost Without Insurance (2026): Onglyza, Kombiglyze & Generic Status

Last reviewed: Oct 18, 2026 Next review due: Jan 2027 Prices are volatile, verify before you buy

By Vincent Couey, RxGrab founder. Pricing cross-checked against Drugs.com, GoodRx, the FDA Orange Book, and manufacturer pages. Updated .

Bottom line, up front

As of October 2026, generic saxagliptin is FDA-approved and marketed in the United States (approved July 31, 2023), and AstraZeneca's brand Onglyza is listed as discontinued in the FDA Orange Book. Generic saxagliptin 5 mg runs about $48 to $64 for 30 tablets with a GoodRx or SingleCare coupon, against a typical pharmacy retail price near $500 to $525. Ask for the generic and compare coupon prices across pharmacies before you fill.

Shop the savings

Cut the cost around your prescriptions

As an Amazon Associate I earn from qualifying purchases.

On this page
  1. What is saxagliptin, and what does it cost?
  2. Is there a generic for Onglyza in 2026?
  3. How much does Kombiglyze XR cost?
  4. Which cash-pay levers actually work?
  5. How does saxagliptin compare with drugs that went generic?
  6. How should you decide your saxagliptin path?
  7. Frequently asked questions

Saxagliptin used to be the kind of drug that quietly punished the uninsured. It was never a headline specialty biologic costing thousands a month, and it was not a $4 generic either. For years it sat in an awkward middle: a brand-only DPP-4 inhibitor priced near $529 a month. That changed when the FDA approved generic saxagliptin on July 31, 2023; brand Onglyza is now listed as discontinued, and the generic runs about $48 to $64 for 30 tablets with a coupon. If you are paying cash, that distinction is the whole story, and many cost guides still get the generic status wrong. This page fixes that with verified figures and a clear path.

What is saxagliptin, and what does it cost?

Saxagliptin is a DPP-4 inhibitor, an oral medication for type 2 diabetes sold under the brand name Onglyza by AstraZeneca, and in a fixed-dose combination with extended-release metformin as Kombiglyze XR. DPP-4 inhibitors work by blocking dipeptidyl peptidase-4, which prolongs the body's own incretin hormones and improves blood-sugar control with a low risk of hypoglycemia. It is taken once daily, which makes it a convenient maintenance drug, and an expensive one if your plan does not cover it.

The cash math has changed. Brand Onglyza ran about $529 for a 30-tablet supply of the 2.5 mg strength at cash retail, per the Drugs.com price guide accessed 2026-05-30, which is more than $6,300 a year for a single once-daily pill. Brand Onglyza is now discontinued, and generic saxagliptin costs about $48 to $64 for 30 tablets with a coupon, against a typical pharmacy retail price near $500 to $525. At about $48 a month, an uninsured patient is looking at roughly $576 a year in OOP cost.

ProductStrengthCash price (30 tablets)Notes
Onglyza (brand)2.5 mg~$529Discontinued; last Drugs.com cash retail, 2026-05-30
Generic saxagliptin, no coupon5 mg~$500-$525Typical pharmacy retail price; brand Onglyza 5 mg discontinued
Generic saxagliptin5 mg~$48-$64GoodRx/SingleCare coupon, October 2026; retail near $500-$525
Saxagliptin/metformin ER (generic)saxagliptin + ER metforminVerify live priceBrand Kombiglyze XR discontinued; generic marketed

All figures are time- and location-variable. Treat each as "approximately, as of the date shown, verify current" rather than a guaranteed quote.

Q

Why is a single once-daily pill so expensive without insurance?

It usually is not anymore. A drug's cash price collapses when a marketed generic competes with it, often by more than 90 percent, and generic saxagliptin has been sold since 2023. The high retail number is a list price; a coupon on the generic is the realistic price. For deeper background on why brand-versus-generic status is the single biggest cost lever, see our guide on generic versus brand-name drugs.

Is there a generic for Onglyza in 2026?

Yes. Generic saxagliptin has been FDA-approved since July 31, 2023 and is sold in the United States. On that date the FDA approved generic applications (each an ANDA) from Aurobindo, Mylan and Glenmark, and both strengths of brand Onglyza are now listed as discontinued. An earlier version of this guide said only tentative approvals were on file and that no generic was for sale; that was wrong, and correcting it is the single most important change this guide makes.

You can confirm this yourself. The FDA Orange Book, maintained by the Center for Drug Evaluation and Research (CDER), lists approved drug products and their approval status, including tentative approvals and patent listings, and it is the authoritative place to check before trusting any blog's claim about saxagliptin generic status. The FDA Orange Book now lists Aurobindo, Mylan and Glenmark generic saxagliptin as marketed and brand Onglyza as discontinued.

A cheap saxagliptin generic does exist. Some cost guides and price pages still say no generic is available or that one is years away. That is out of date. Generic saxagliptin has been approved since July 2023 and is listed as marketed by several makers, so ask for it by name and price it with a coupon before paying anything near a brand price.
Source-rigor card · generic status
FDA Orange Book
Authoritative list of approved products and their marketing status. Lists generic saxagliptin as marketed and brand Onglyza as discontinued.
Generic approval
Generic saxagliptin approved July 31, 2023; brand Onglyza listed as discontinued (FDA data as of 2026-10-16).
Marketed generics
Aurobindo, Mylan and Glenmark saxagliptin, plus Dr. Reddy's and Mylan saxagliptin/metformin ER, listed as marketed.
What this rules out
No credentialed reviewer is named here. Generic status is sourced to FDA and manufacturer-adjacent primaries, not to recall.

How much does Kombiglyze XR cost, and is it different?

Kombiglyze XR is a fixed-dose combination of saxagliptin plus extended-release metformin in a single once-daily tablet. The brand is now listed as discontinued, and generic saxagliptin/metformin ER from Dr. Reddy's and Mylan is listed as marketed. That leaves a choice worth raising with your pharmacist and prescriber: metformin on its own is one of the cheapest generics in American pharmacies, frequently under $10 a month and on many $4 generic lists, so the generic combination tablet should be priced against generic saxagliptin plus generic metformin taken separately.

For some patients, two separate generic tablets cost less than the generic combination tablet, and for others the single tablet wins once a coupon is applied. Splitting a combination into two pills is a clinical decision, not only a pricing one, so it belongs with your prescriber. But it is a question worth asking, and almost nobody is told to ask it. If you are weighing combining medications, verify there are no harmful interactions first; the cross-tradition interaction tools at OmniRx cover DPP-4 inhibitor and metformin interactions in detail.

Q

If metformin is nearly free, why was Kombiglyze XR expensive?

Because the price was set by the most expensive component, not the cheapest. While saxagliptin was brand-only, bundling it with a cheap generic like metformin made the combination cost like the brand-only component plus a formulation premium. Now that generic saxagliptin/metformin ER is marketed, ask for the generic and price it with a coupon; the convenience of one pill is real, so compare it with two separate generics before you choose.

Which cash-pay levers actually work for saxagliptin?

A savings lever is any mechanism that lowers what you actually pay at the counter. Now that saxagliptin is sold as a generic, the usual generic levers apply, and one popular lever is a trap for the uninsured. Here is the honest ranking for a cash-pay patient.

  1. Discount coupons, GoodRx or SingleCare. Free, cash-pay, and require no insurance. A generic saxagliptin coupon runs about $48 to $64 for 30 tablets of 5 mg as of October 2026, but coupon prices move with pharmacy, ZIP code, and date, so treat that as "around this much, verify current" and price it live at GoodRx before you go. This is usually the single biggest cut available.
  2. Patient assistance program, AstraZeneca. Manufacturer- and foundation-run programs provide free or low-cost medication to low-income and uninsured patients, subject to income eligibility. Unlike copay cards, a patient assistance program can serve cash-pay and uninsured payers. AstraZeneca's program was built around brand Onglyza, which is now discontinued, so confirm whether it still covers saxagliptin; with the generic near $48 a month by coupon, assistance matters mainly for patients who cannot afford even that. Our patient assistance programs guide walks through the application.
  3. 90-day supply. For a stable maintenance dose, a 90-day fill lowers per-month cost and cuts repeat dispensing fees. It does not change the unit price, but it trims the overhead on a chronic medication.
  4. Therapeutic or in-class switch. If even the generic coupon price is too high, ask your prescriber whether a different antidiabetic class with cheaper generics fits your treatment plan. This is the lever that can cut the cost further, and it is a clinical conversation, not a coupon.
Manufacturer copay cards are not for you if you are uninsured. Copay cards almost always exclude cash-pay, uninsured, and government-insured patients such as those on Medicare or Medicaid. They require commercial, private insurance. This cluster's audience is cash-pay and uninsured, so a copay card is the wrong lever, and presenting it as a solution would be misleading. Use coupons and patient assistance instead.

Note one lever worth checking. Mark Cuban's Cost Plus Drugs is excellent for established generics, where its transparent model of manufacturer cost plus a 15 percent markup plus a pharmacy fee and shipping produces remarkable prices on drugs like atorvastatin or pitavastatin calcium. Generic saxagliptin is marketed, so check whether Cost Plus lists it at costplusdrugs.com and compare its total with a local coupon price.

How does saxagliptin compare with drugs that went generic?

A "brand-drug near-miss" is a drug whose cash price stays painful until a generic arrives. Saxagliptin was a textbook example until generics launched in 2023, and it now sits with the drugs that have already crossed the generic line. The chart below plots representative cash prices on a logarithmic scale, because the gap between a brand specialty drug and its generic is so large it does not fit a linear axis.

$10 $100 $1,000 $10,000 Saxagliptin $529 brand ~$48 generic Teriflunomide ~$8,500 brand ~$30 generic Dimethyl fumarate ~$7,800 brand ~$41 generic Pitavastatin ~$237 brand ~$37 generic Atorvastatin ~$8 generic Rosuvastatin ~$8 generic

Swipe sideways to see the whole chart.

Representative cash prices, 30-day supply, log scale. Brand bars teal, marketed generic bars mint. Brand Onglyza is discontinued; its bar shows the last brand cash price. Saxagliptin generic price is a GoodRx coupon, October 2026; other figures approximate as of 2026-05-30 per Drugs.com, GoodRx, and SingleCare; verify current before relying on any single number.

Read the chart top to bottom and the lesson is plain. Teriflunomide (brand Aubagio), an oral disease-modifying therapy for relapsing multiple sclerosis (MS), runs roughly $8,000 to $9,300 a month as a brand, yet its marketed generic lands near $28 to $40 with a coupon, per GoodRx and SingleCare pricing, a saving above 99 percent. Dimethyl fumarate (brand Tecfidera), another oral MS therapy near $7,800 a month as a brand, drops to roughly $41 and up as a marketed generic. Pitavastatin calcium, the high-cost statin sold as brand Livalo near $237 a month, falls to around $37 with a coupon as a generic, and is carried on Cost Plus Drugs. And the everyday high-intensity statins, atorvastatin and rosuvastatin, sit near $6 to $10 a month as long-established generics.

Saxagliptin follows the same pattern as every other row: once generics arrived in 2023, the coupon price fell from the $500 range to about $48 for 30 tablets, the way pitavastatin and the statins already had.

$529
Brand Onglyza (now discontinued), 30 tablets, cash, 2026-05-30
3
Generic saxagliptin makers listed as marketed, October 2026
~$48
Generic saxagliptin 5 mg, 30 tablets, GoodRx coupon, Oct 2026
>99%
Typical brand-to-generic drop in this class once generics arrive

How should you decide your saxagliptin path?

A decision path is just the cash-pay ranking applied to your actual situation. Work it top to bottom and stop at the first option that fits.

  1. Are you uninsured with low income? Price generic saxagliptin with a coupon first; at about $48 a month it may already be within reach. If it is not, ask AstraZeneca whether its patient assistance program still covers saxagliptin now that brand Onglyza is discontinued, and check foundation programs. Income documentation and a prescriber signature are typically required.
  2. Are you above the assistance income threshold? Run a generic saxagliptin coupon at GoodRx or SingleCare and price it at several pharmacies. About $48 to $64 for 30 tablets of 5 mg is typical as of October 2026, but verify it live because coupon prices move.
  3. Is the cost still too high? Ask your prescriber about another antidiabetic class with cheaper generics. A clinical switch is the lever that can cut the cost further rather than discount it.
  4. On a stable dose? Move to a 90-day supply to trim per-month cost and dispensing fees.
  5. Still on brand Onglyza? The brand is discontinued. Ask your pharmacist to fill generic saxagliptin and price it with a coupon. Do not stop or skip doses while you switch.

If your costs are driven by other high-priced brand or specialty drugs alongside saxagliptin, the enrollment and assistance mechanics in our specialty pharmacy guide apply to the whole basket, not just one molecule. And if you want the science behind DPP-4 inhibitors and where they fit in type 2 diabetes management, Health Britannica covers the incretin pathway and oral diabetes drug classes in depth.

Frequently asked questions

Is there a generic for Onglyza (saxagliptin) in 2026?

Yes. The FDA approved generic saxagliptin on July 31, 2023, and several makers including Aurobindo, Mylan and Glenmark are listed as marketing it. Brand Onglyza is now listed as discontinued in the FDA Orange Book.

How much does Onglyza cost without insurance?

Brand Onglyza is discontinued. Generic saxagliptin 5 mg has a typical retail price near $500 to $525 for 30 tablets, but about $48 to $64 with a GoodRx or SingleCare coupon as of October 2026. Coupon prices vary by pharmacy and date, so verify before you go.

What is Kombiglyze XR and what does it cost?

Kombiglyze XR is a fixed-dose combination of saxagliptin plus extended-release metformin. The brand is discontinued, and generic saxagliptin/metformin ER is marketed. Because metformin alone is one of the cheapest generics available, some patients ask their pharmacist to price the generic combination tablet against generic saxagliptin plus generic metformin taken separately.

Do manufacturer copay cards help uninsured saxagliptin patients?

Usually not. Manufacturer copay cards almost always exclude cash-pay, uninsured, and government-insured patients such as those on Medicare or Medicaid. They require commercial insurance. For the uninsured, a PAP is the relevant lever, not a copay card.

Can Mark Cuban Cost Plus Drugs sell saxagliptin cheaply?

Cost Plus Drugs is strongest on established generics, and generic saxagliptin has been marketed since 2023. Check whether costplusdrugs.com lists it and compare its total with a local coupon price.

Sources cited · this article
  1. Drugs.com. Onglyza (saxagliptin) price guide. Accessed 2026-05-30. Last brand cash price before discontinuation.
  2. U.S. Food & Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, and Drugs@FDA. Generic saxagliptin and saxagliptin/metformin ER approvals (July 31, 2023) and discontinued status of brand Onglyza and Kombiglyze XR. Verify directly.
  3. GoodRx. Saxagliptin and teriflunomide pricing pages. Teriflunomide coupon range accessed 2026-05-30; generic saxagliptin coupon price checked October 2026; vary by pharmacy and date.
  4. SingleCare. Teriflunomide and saxagliptin discount pricing. Teriflunomide accessed 2026-05-30; generic saxagliptin checked October 2026.
  5. Mark Cuban Cost Plus Drug Company. costplusdrugs.com transparent pricing model and pitavastatin calcium availability. Verify live.
  6. AstraZeneca. Onglyza and Kombiglyze XR manufacturer pages and patient assistance program eligibility. Verify current.
, DeepSynthesis Network

RxGrab is part of a research network.

Separate topical publications, one publisher, same editorial standards, no cross-site bias. Each site covers one vertical with the same data-first methodology.

Sources and standards behind this page

Prescription prices in the United States are set through a documented chain of list prices, pharmacy benefit contracts and federal programs, and the sources below are the primary public records of how that chain works. They are linked so a reader can check a claim here without taking this page's word for it.

This page describes how prescription pricing and discount programs work. It is not medical advice, and what a given person pays depends on their own plan, pharmacy and prescriber.